The Latest Analyst Ratings for Mind Medicine
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Mind Medicine (NASDAQ:MNMD) within the last quarter, with 7 total bullish ratings and 3 somewhat bullish ratings. The average 12-month price target for Mind Medicine is $34.3, a decrease of 54.27% from the previous average price target of $75.00.
June 28, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mind Medicine has received positive ratings from analysts, with an average 12-month price target of $34.3, a decrease from the previous target.
The bullish ratings from analysts indicate a positive outlook for Mind Medicine. However, the decrease in the average price target suggests that while the outlook is positive, expectations may have been adjusted downwards.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100